This document discusses various topics related to pharmaceutical formulations and drug delivery systems including: 1) development of topical formulations of boswellic acids for rheumatoid arthritis, 2) supramolecular nanomedicine for recovery of toxic metals, and 3) design of oral and colon targeted drug delivery systems. It also mentions evaluation of finished goods quality assurance, product composition effects on material selection, and stability testing of colorants and changes in tablet properties like hardness and dissolution with formulation modifications.
This document discusses various topics related to pharmaceutical formulations and drug delivery systems including: 1) development of topical formulations of boswellic acids for rheumatoid arthritis, 2) supramolecular nanomedicine for recovery of toxic metals, and 3) design of oral and colon targeted drug delivery systems. It also mentions evaluation of finished goods quality assurance, product composition effects on material selection, and stability testing of colorants and changes in tablet properties like hardness and dissolution with formulation modifications.
This document discusses various topics related to pharmaceutical formulations and drug delivery systems including: 1) development of topical formulations of boswellic acids for rheumatoid arthritis, 2) supramolecular nanomedicine for recovery of toxic metals, and 3) design of oral and colon targeted drug delivery systems. It also mentions evaluation of finished goods quality assurance, product composition effects on material selection, and stability testing of colorants and changes in tablet properties like hardness and dissolution with formulation modifications.
This document discusses various topics related to pharmaceutical formulations and drug delivery systems including: 1) development of topical formulations of boswellic acids for rheumatoid arthritis, 2) supramolecular nanomedicine for recovery of toxic metals, and 3) design of oral and colon targeted drug delivery systems. It also mentions evaluation of finished goods quality assurance, product composition effects on material selection, and stability testing of colorants and changes in tablet properties like hardness and dissolution with formulation modifications.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 1
1.
Formulation and evaluation of topical formulations of Bosweellic acids guggulosterones
for the treatment of rheumatoid arthritis 2. Supramolecular: Nanomedicine and nanotechnology pre-concentration, separation and recovery of toxic trace metal 3. Supercritical fluid technology 4. Studies on design and development of dissolvable oral drug delivery systems of a poorly water soluble non-steroidal anti-inflammatory drug 5. Designing of a polyherbal formulation for metabolic disorder 6. Development of lipidic drug delivery system for bioavailability improvement of the poorly water soluble antihypertensive drug 7. Formulation, development of rapidly dissolving films containing anti-histaminic drug 8. Formulation and Evaluation of colon targeted drug delivery systems 9. Formulation, development and evaluation of controlled drug delivery of analgesics via novel routes 10. Rotary Tableting Press 11. Finished Goods Quality Assurance. 12. The Perfect Excipient 13. Product Composition Affects Material Selection 14. Fractional Experimental Design. Study of the Incompatibility of Benzocaine in Throat Lozenges 15. Moisture content of tablet 16. Stability of the colorant 17. Changes in tablet hardness. friability. dissolution rate 18. Formulation and evaluation of colon targeted drug delivery system of mebeverine hydrochloride 19. Any significant pharmaceutical problem with the drug product related to its formulation, drug delivery and bio-availability. 20. Methods and types of dosage form which already exsits in the market. 21. Points you have to study and review for literature purpose: 22. One should have to study the history of the drug thoroughly. 23. Early and common problems related to exsisting dosage forms.